MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
Harvard Bioscience ROE Ratio 2011-2026 | HBIO
Annual ROE Ratio Harvard Bioscience
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.67 | -13.18 | -0.35 | -10.19 | -5.74 | -3.53 | -1.07 | -5.97 | -24.54 | 2.47 | -1.94 | 2.27 | 3.99 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.99 | -24.54 | -4.8 |
Quarterly ROE Ratio Harvard Bioscience
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -369.94 | -368.54 | -358.39 | -18.53 | -20.19 | -14.51 | -11.46 | -2.13 | -6.86 | -9.92 | -5.48 | -10.6 | -10.82 | -6.31 | -9.97 | -1.61 | -3.04 | -4.25 | -5.79 | -9.38 | -8.71 | -10.48 | -8.73 | -5.74 | -2.95 | -0.05 | -1.52 | -3.53 | -5.76 | -5.96 | -4.66 | -1.07 | -4.13 | -5.89 | -6.4 | -5.97 | -26.23 | -25.05 | -23.61 | -24.54 | -2.47 | -0.71 | -0.09 | 2.78 | 2.0 | 0.3 | -0.95 | -1.92 | 0.04 | 0.95 | 1.87 | 2.27 | 1.9 | 2.05 | 2.74 | 0.77 | 0.03 | 1.43 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.78 | -369.94 | -24.41 |
ROE Ratio of other stocks in the Medical instruments industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
7991.72 | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
-7.35 | $ 19.93 | 0.99 % | $ 10.2 B | USA |
 |
Luminex Corporation
LMNX
|
2.93 | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
-50.84 | - | -9.52 % | $ 20.6 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
47.18 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
1.88 | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
-23.1 | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
12.92 | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
16.51 | - | -0.02 % | $ 16.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
-89.16 | $ 8.71 | 3.75 % | $ 176 M | USA |
 |
Alcon
ALC
|
-2.82 | $ 81.19 | 0.07 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
-9.7 | $ 36.37 | -1.57 % | $ 1.71 B | USA |
 |
Repro Med Systems
KRMD
|
-67.51 | $ 5.37 | -1.56 % | $ 245 M | USA |
 |
Haemonetics Corporation
HAE
|
20.43 | $ 65.87 | -0.15 % | $ 3.32 B | USA |
 |
electroCore
ECOR
|
-253.08 | $ 6.83 | -3.73 % | $ 37.7 K | USA |
 |
AngioDynamics
ANGO
|
-18.58 | $ 10.2 | 2.2 % | $ 417 M | USA |
 |
ICU Medical
ICUI
|
-5.99 | $ 149.04 | -0.66 % | $ 3.63 B | USA |
 |
InfuSystem Holdings
INFU
|
0.04 | $ 8.14 | 1.12 % | $ 168 M | USA |
 |
The Cooper Companies
COO
|
4.55 | $ 80.95 | 0.72 % | $ 16.1 B | USA |
 |
Masimo Corporation
MASI
|
-28.99 | $ 134.5 | -1.29 % | $ 7.17 B | USA |
 |
Glaukos Corporation
GKOS
|
-29.16 | $ 117.26 | -1.43 % | $ 5.68 B | USA |
 |
Merit Medical Systems
MMSI
|
8.73 | $ 80.09 | -0.19 % | $ 4.66 B | USA |
 |
OraSure Technologies
OSUR
|
-4.75 | $ 2.78 | -0.54 % | $ 207 M | USA |
 |
Isoray
ISR
|
-27.27 | - | 0.03 % | $ 108 M | USA |
 |
iRhythm Technologies
IRTC
|
-124.62 | $ 150.09 | 0.74 % | $ 4.68 B | USA |
 |
LeMaitre Vascular
LMAT
|
13.06 | $ 84.08 | 0.26 % | $ 1.89 B | USA |
 |
Intuitive Surgical
ISRG
|
14.13 | $ 505.88 | -0.33 % | $ 180 B | USA |
 |
STERIS plc
STE
|
9.31 | $ 261.25 | -0.23 % | $ 25.8 B | USA |
 |
NeuroMetrix
NURO
|
-54.54 | - | 5.05 % | $ 9.02 M | USA |
 |
Microbot Medical
MBOT
|
-238.61 | $ 1.84 | -1.34 % | $ 18.8 M |  Israel |
 |
Nephros
NEPH
|
-18.84 | $ 4.4 | 0.23 % | $ 45.7 M | USA |
 |
Utah Medical Products
UTMD
|
3.34 | $ 60.16 | -2.42 % | $ 218 M | USA |
 |
Milestone Scientific
MLSS
|
-80.81 | $ 0.29 | -0.7 % | $ 23.1 M | USA |
 |
Envista Holdings Corporation
NVST
|
-38.12 | $ 23.07 | -1.28 % | $ 3.97 B | USA |
 |
Pro-Dex
PDEX
|
24.51 | $ 38.84 | -1.43 % | $ 128 M | USA |
 |
Predictive Oncology
POAI
|
6250.62 | - | - | $ 31.1 M | USA |
 |
Pulse Biosciences
PLSE
|
-95.15 | $ 13.69 | 0.48 % | $ 658 M | USA |
 |
Becton, Dickinson and Company
BDX
|
6.61 | $ 201.67 | 0.29 % | $ 58 B | USA |
 |
Repligen Corporation
RGEN
|
1.81 | $ 151.86 | -2.88 % | $ 8.46 M | USA |
 |
ResMed
RMD
|
23.19 | $ 251.52 | -2.37 % | $ 36.7 B | USA |
 |
BioLife Solutions
BLFS
|
-5.78 | $ 22.08 | -2.21 % | $ 1.02 B | USA |
 |
Stereotaxis
STXS
|
-126.74 | $ 2.26 | -3.21 % | $ 182 M | USA |
 |
Retractable Technologies
RVP
|
-13.64 | $ 0.69 | 0.16 % | $ 20.7 M | USA |
 |
STAAR Surgical Company
STAA
|
-5.09 | $ 18.79 | -0.8 % | $ 923 M | USA |
 |
Teleflex Incorporated
TFX
|
1.63 | $ 105.0 | -0.43 % | $ 4.92 B | USA |
 |
West Pharmaceutical Services
WST
|
18.37 | $ 226.43 | -2.61 % | $ 16.5 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
-46.86 | $ 12.28 | 0.04 % | $ 2.5 B | USA |